27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Nantkwest Inc (NASDAQ:NK)'s enterprise value has fallen to about $120 million, limiting any potential downside, according to Citigroup.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Analyst Wendy Nicholson downgraded NantKwest from Sell to Neutral and maintained a $3 price target.
The Thesis
Apart from the fall in enterprise value, the 10-Q NantKwest filed this week showed that the company is enrolling patients in three clinical trials, bringing its number of ongoing clinical trials to six, Nicholson said in a note. (See the analyst's track record here.)
Although Citi upped its rating, the firm still remains sidelined due to NanKwest's history of missing timelines, the analyst said.
Also, Nicholson said the NANT vaccine studies include several proprietary agents not owned by the company.
Wall Street Vet Reveals $9 Options Secret
Tired of tiny stock gains? This 40-year insider is spilling the beans on how to turn small investments into 600% returns. Get his proven options strategy in a FREE webinar.—Register now – seats are limited!
Many of the company's trials are run at a single center that has strong ties to the Nant ecosystem of entities, Nicholson said.
Citing the 10-Q, the analyst said the company has seen increases in manufacturing costs and "sporadic decreases in manufacturing yield of both haNK and taNK cells."
NantKwest's corporate transparency is "relatively low," Nicholson said.
The Price Action
Nantkwest shared have declined about 27 percent year-to-date. The stock was trading down 2.45 percent to $3.19 at the time of publication Friday.
Related Links:
Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates
The Week Ahead In Biotech: Conferences, PDUFA Dates And IPOs
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.